Administration of recombinant human erythropoietin in patients with gynecological cancer before radical surgery

Clinical and Experimental Obstetrics and Gynecology

Volumn 32, Issue 2, 2005, Pages 129-131

  Dousias, V ^a   Stefos, T ^a   Navrozoglou, I ^a   Staikos, I ^a   Ditto, A ^b   Paraskevaidis, E ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b Natl Inst for Stud/Treatm Tumors   (Italy)

Author keywords

Anemia; Erythropoietin; Gynecological cancer

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIUM CANCER; FEMALE; FERRITIN BLOOD LEVEL; GYNECOLOGIC CANCER; HEMOGLOBIN DETERMINATION; HUMAN; INTRAOPERATIVE PERIOD; IRON THERAPY; OVARY CANCER; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER;

ADULT; AGED; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; IRON COMPOUNDS; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 23044455951     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Blumberg N., Heal J., Chuang C., Murphy P., Agarwal M.: "Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence". Ann. Surg., 1988, 207, 410.
2. Tartter P.I., Quintero S., Barron D.M.: "Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations". Am. J. Surg., 1986, 152, 479.
3. Eisenkop S.M., Spirtos N.M., Montag T.W., Moossazadeh J., Warren P., Hendrickson M.: "The clinical significance of blood transfusion at the time of radical hysterectomy". Obstet. Gynecol., 1990, 76, 110.
4. Jeekel J.: "Autologous blood donation and erythropoietin alfa in cancer surgery". Semin. Hematol., 1996, 33, 43.
5. Levine E.A., Laborde C., Hambrick E. et al.: "Influence of eryrthropoietin on transfusion requriments in patients receiving preoperative chemoradiotherapy for rectal cancer". Dis. Colon Rectum., 1999, 42, 1065.
6. Kettelhack C., Hones C., Messinger D. et al.: "Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemia patients undergoing right hemicolectomy for carcinoma". Br. J. Surg., 1998, 85, 63.
7. Glaser C.M., Millesi W., Kornek G.V. et al: "Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx". Int. J. Radiat. Oncol. Biol. Phys., 2001, 50, 705.
8. Kosmadakis N., Messaris E., Maris A., Katsaragakis S., Leandros E., Konstadoulakis M., Androulakis G.: "Perioperative erythropoietin administration in patients with gastrointestinal tract cancer". Ann. Surg., 2003, 237, 417.
9. Del Mastro L., Venturini M., Lionetto R., Garrone O.: "Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia". J. Clin. Oncol., 1997, 75, 2715.
10. Demetri G.D., Kris M., Wade J., Degas L.: "Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of desease or tumor type: results from a prospective community oncology study". J. Clin. Oncol., 1998, 16, 3412.
11. Glaspy J., Cavill I.: "Role of iron in optimizing responses of anemic cancer patients to erythropoietin". Oncology, 1999, 13, 461.
12. Dousias V., Paraskevaidis E., Dalkalitsis N., Tsanadis G., Navrozoglou I., Lolis D.: "Recombinant human erythropoietin in mildly anemic women before total hysterectomy". Clin. Exp. Obstet. Gynecol., 2003, 235.
13. Ad Hoc Committee for the National Kidney Foundation: "Statement on the clinical use of recombinant erythropoietin in anemia of and-stage kidney disease". Am. J. Kidney Dis., 1989, 14, 163.
14. Chun T.Y., Martin S., Lepor H.: "Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic hysterectomy". Urology, 1997, 50, 727.